Arbutus Biopharma Corporation (ABUS)

NASDAQ: ABUS · Real-Time Price · USD

4.530

-0.170 (-3.62%)

At close: Mar 6, 2026, 4:00 PM EST

4.490

-0.040 (-0.88%)

After-hours: Mar 6, 2026, 7:57 PM EST

Arbutus Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Mar '26 Mar 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Market Capitalization	871	620	419	365	526	301	Upgrade
Market Cap Growth	33.64%	47.80%	15.00%	-30.72%	74.57%	74.57%	Upgrade
Enterprise Value	782	496	285	189	556	353	Upgrade
Last Close Price	4.53	3.27	2.50	2.33	3.89	3.55	Upgrade
PS Ratio	59.65	100.41	23.11	9.34	47.89	43.60	Upgrade
PB Ratio	11.23	6.36	3.95	2.66	3.11	2.96	Upgrade
P/TBV Ratio	11.26	6.36	3.95	2.66	3.11	-	Upgrade
EV/Sales Ratio	53.55	80.32	15.69	4.85	50.59	51.00	Upgrade
Debt / Equity Ratio	0.06	0.06	0.08	0.09	0.11	0.22	Upgrade
Net Debt / Equity Ratio	-1.15	-1.20	-1.17	-1.25	-1.02	-0.99	Upgrade
Net Debt / EBITDA Ratio	2.91	1.70	1.61	2.78	2.46	1.82	Upgrade
Net Debt / FCF Ratio	1.96	1.79	1.42	4.79	2.52	1.95	Upgrade
Asset Turnover	0.12	0.05	0.11	0.20	0.06	0.06	Upgrade
Quick Ratio	18.31	8.03	5.71	4.51	13.92	13.06	Upgrade
Current Ratio	18.80	8.15	5.87	4.60	14.32	13.39	Upgrade
Return on Equity (ROE)	-45.88%	-68.76%	-59.99%	-45.35%	-56.19%	-72.97%	Upgrade
Return on Assets (ROA)	-16.46%	-31.68%	-28.70%	-19.76%	-26.22%	-29.51%	Upgrade
Return on Capital Employed (ROCE)	-33.90%	-60.30%	-64.00%	-38.90%	-37.10%	-44.90%	Upgrade
Earnings Yield	-4.85%	-11.28%	-17.38%	-19.05%	-14.49%	-21.15%	Upgrade
FCF Yield	-5.21%	-10.50%	-20.74%	-9.84%	-12.99%	-17.14%	Upgrade
Buyback Yield / Dilution	-5.88%	-11.84%	-9.95%	-42.07%	-40.10%	-32.83%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.